Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,204 | -67,138 | -46,520 | -26,271 | -24,623 |
| Depreciation Amortization | 1,663 | 9,175 | 7,518 | 4,779 | 2,151 |
| Income taxes - deferred | 13 | -1,877 | -1,839 | -1,839 | 123 |
| Accounts receivable | -4,383 | -6,218 | -5,678 | -5,628 | -2,725 |
| Accounts payable and accrued liabilities | 3,896 | 582 | 2,155 | 302 | 187 |
| Other Working Capital | -11,647 | -7 | -3,411 | -6,505 | -10,074 |
| Other Operating Activity | 14,223 | 23,828 | 12,120 | 4,731 | 13,531 |
| Operating Cash Flow | $-25,439 | $-41,655 | $-35,655 | $-30,431 | $-21,430 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,917 | -134,689 | -131,808 | 0 | N/A |
| PPE Investments | -3,333 | -5,437 | -3,836 | -1,799 | -402 |
| Net Acquisitions | N/A | -26,419 | -26,419 | -26,114 | N/A |
| Investing Cash Flow | $16,584 | $-166,545 | $-162,063 | $-27,913 | $-402 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -35 | -122 | -88 | -55 | -24 |
| Common Stock Issued | 1,077 | 3,325 | 2,487 | 2,020 | 1,296 |
| Other Financing Activity | -314 | -1,688 | -134 | -88 | -56 |
| Financing Cash Flow | $728 | $1,515 | $2,265 | $1,877 | $1,216 |
| Beginning Cash Position | 122,948 | 329,633 | 329,633 | 329,633 | 329,633 |
| End Cash Position | 114,821 | 122,948 | 134,180 | 273,166 | 309,017 |
| Net Cash Flow | $-8,127 | $-206,685 | $-195,453 | $-56,467 | $-20,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,439 | -41,655 | -35,655 | -30,431 | -21,430 |
| Capital Expenditure | -3,338 | -5,632 | -3,845 | -1,807 | -402 |
| Free Cash Flow | -28,777 | -47,287 | -39,500 | -32,238 | -21,832 |